According to the American Cancer Society data, 1 out of every 6 men is diagnosed with prostate cancer during his lifetime. This disease, which is the second most common cause of cancer deaths in men after lung cancer, can be treated if diagnosed early.
How is Prostate Cancer Diagnosed Early?
There are no typical early symptoms of prostate cancer and it manifests itself only with complaints that occur in the advanced period. At this stage, the person may not be able to get rid of this disease. For this reason, it is very important to detect the disease in the early period when it is still limited to the prostate, that is, when it does not produce any clinical findings. For early diagnosis, those with a family history of prostate cancer should apply to a urology specialist for prostate examination once a year after the age of 45 and those without 50 years of age.
How is Prostate Cancer Diagnosed?
Secreted from the prostate and passed into the blood at a certain rate. PSAMeasuring the level of a protein in the blood that we call ” finger examination are the methods that constitute the first step in diagnosis. In these two diagnostic methods, if findings that raise suspicion of prostate cancer are detected, it is necessary to make a definitive diagnosis. prostate biopsytissue sampling is required.
How is Prostate Biopsy Performed?
Classical prostate biopsy is performed by entering through the anus under ultrasound guidance, and tissue samples are taken by blindly shooting at 10-12 points of the prostate. However, with this method, only 70-75% of prostate cancer cases can be diagnosed, and a significant portion of cancer cases are missed. It is recommended to perform repeated biopsies in cases where cancer is not diagnosed after biopsy, but whose cancer suspicion continues, which poses a risk of serious infection, bleeding and pain in patients.
What is MR Fusion Biopsy?
MR Fusion Biopsy is a highly sensitive “intelligent biopsy” method that detects the foci with suspected cancer in the prostate and enables point shooting towards these targets. In the process, first of all, multislice MR images of the prostate are examined and suspicious foci in terms of cancer are marked. Then, the MR images are processed with the help of a special software and combined with the ultrasound images, and after the images are made 3D, the biopsy needle is directed to the marked suspicious points with the help of a robotic arm, and targeted biopsy is performed.